Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02761070
Brief Title: Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III (RE-GEND)

First Submitted : April 28, 2016
First Submitted that Met QC Criteria : May 2, 2016
First Posted : May 4, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 30, 2020
Last Update Posted : September 1, 2020